Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Christopher Marlett Insider Profile

60 Followers

Christopher Marlett, Director, Ten Percent Owner at eXoZymes, holds 3.81M shares in eXoZymes (Ticker: EXOZ), holds 574.74K shares in Medivation (Ticker: MDVN), holds 180.85K shares in MDB Capital Holdings, LLC Class A (Ticker: MDBH).

Christopher Marlett's Trading History

MDBHMDB Capital Holdings, LLC Class A		Oct 16, 2026Co-Founder, Director, Ten Percent OwnerInformative Buy1.77K$307.44K
CUECue Biopharma		Dec 31, 2019DirectorInformative Sell402.21K$16.04M
MDVNMedivation		―――$46.44M
EXOZeXoZymes		―Director, Ten Percent Owner―$15.73M
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Christopher Marlett insider profile FAQ

What is the percentage of profitable transactions made by Christopher Marlett?
The percentage of profitable transactions made by Christopher Marlett is 40%.
What is the average return per transaction made by Christopher Marlett?
The average return per transaction made by Christopher Marlett is 51.20%.
What stocks does Christopher Marlett hold?
Christopher Marlett holds: EXOZ, MDVN, CUE, MDBH stocks.
What was Christopher Marlett's most profitable transaction?
Christopher Marlett’s most profitable transaction was an Informative Buy of CUE stock on December 26, 2018. The return on the trade was 267.50%.
What is Christopher Marlett's role in eXoZymes?
Christopher Marlett's role in eXoZymes is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.